T22	Exp 120 134	The regulation
T23	Exp 220 245	the predominant producers
T24	Exp 319 321	we
T25	Exp 423 428	which
T26	Exp 301 318	the present study
T27	Exp 331 342	the control
T28	Exp 533 561	the Ca2+ ionophore ionomycin
T29	Exp 671 688	the IL-2 promoter
T30	Exp 827 841	the chi B site
T31	Exp 850 882	the strongest inducible activity
T32	Exp 884 907	the NF-AT binding sites
T33	Exp 915 946	either no or only weak activity
T34	Exp 1084 1086	it
T35	Exp 1174 1188	their capacity
T36	Exp 1206 1218	the activity
T37	Exp 1222 1239	the IL-2 promoter
T38	Exp 1261 1271	the status
T39	Exp 1421 1429	the IL-2
T40	Exp 1469 1497	the non-IL-2-producing cells
T41	Exp 1581 1604	the IL-2 NF-chi B probe
T42	Exp 1614 1641	the constitutive generation
T43	Exp 1872 1876	that
T44	Exp 1877 1899	the IL-2 NF-chi B site
T45	Exp 1921 1933	the activity
T46	Exp 1937 1954	the IL-2 promoter
T47	Exp 1846 1859	These results
T48	Exp 2070 2081	these cells
R4	Coref Anaphora:T25 Antecedent:T49
R5	Coref Anaphora:T34 Antecedent:T8
R6	Coref Anaphora:T35 Antecedent:T50
T1	Protein 0 13	Interleukin-2
T2	Protein 138 156	interleukin (IL)-2
T3	Protein 249 253	IL-2
T4	Protein 292 296	IL-2
T5	Protein 346 350	IL-2
T6	Protein 454 458	IL-2
T7	Protein 675 679	IL-2
T8	Protein 978 982	IL-2
T9	Protein 1200 1204	IL-2
T10	Protein 1226 1230	IL-2
T11	Protein 1275 1279	IL-2
T12	Protein 1425 1429	IL-2
T13	Protein 1477 1481	IL-2
T14	Protein 1585 1589	IL-2
T15	Protein 1664 1668	IL-2
T16	Protein 1720 1723	p50
T17	Protein 1724 1727	p65
T18	Protein 1824 1828	IL-2
T19	Protein 1881 1885	IL-2
T20	Protein 1941 1945	IL-2
T21	Protein 2051 2055	IL-2
T49	Exp 409 422	B cell clones
T50	Exp 1128 1151	seven EBV-B cell clones
